MARKET

NVCN

NVCN

Neovasc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.460
-0.140
-8.75%
After Hours: 1.460 0 0.00% 16:36 03/31 EDT
OPEN
1.580
PREV CLOSE
1.600
HIGH
1.611
LOW
1.380
VOLUME
262.66K
TURNOVER
--
52 WEEK HIGH
8.65
52 WEEK LOW
1.380
MARKET CAP
16.25M
P/E (TTM)
3.967
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NVCN stock price target is 7.00 with a high estimate of 9.00 and a low estimate of 5.00.

EPS

NVCN News

More
  • Canaccord Genuity Maintains Buy on Neovasc, Lowers Price Target to $3
  • Benzinga · 14h ago
  • Neovasc Announces Fourth Quarter and Full Year 2019 Financial Results
  • GlobeNewswire · 1d ago
  • Neovasc Q4 EPS $(1.45) Down From $(0.77) YoY, Sales $565.821K Up From $523.424K YoY
  • Benzinga · 1d ago
  • Neovasc Q4 Sales $565.821K Up From $523.424K YoY
  • Benzinga · 1d ago

Industry

Advanced Medical Equipment & Technology
-1.24%
Healthcare Equipment & Supplies
-0.66%

Hot Stocks

Symbol
Price
%Change

About NVCN

Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.
More

Webull offers kinds of Neovasc Inc stock information, including NASDAQ:NVCN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVCN stock news, and many more online research tools to help you make informed decisions.